Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine plus Rituximab in CLL (CLL2M)
NCT00274989Phase 2Completed
- Sponsor
- German CLL Study Group
- Start
- Nov 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in chronic lymphocytic leukemia (CLL), sponsored by German CLL Study Group. Started Nov 2005; status: completed.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00274989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274989.